- Home
- FLNT vs ESLA Comparison
FLNT vs ESLA Comparison
Compare FLNT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNT | ESLA |
|---|---|---|
| Founded | 2001 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 48.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNT | ESLA |
|---|---|---|
| Price | $2.07 | $1.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $16.00 |
| AVG Volume (30 Days) | 18.0K | ★ 243.3K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $212,352,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $0.73 |
| 52 Week High | $3.12 | $3.15 |
Technical Indicators
Market Signals| Indicator | FLNT | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 61.19 | 49.59 |
| Support Level | $1.72 | $1.52 |
| Resistance Level | $1.93 | $2.15 |
| Average True Range (ATR) | 0.10 | 0.30 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 100.00 | 55.84 |
Price Performance
Historical ComparisonAbout FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.